Q32 Bio Shares Are Trading Lower After the Company Reported Worse-than-expected Q2 EPS Results.

BenzingaAug 8 14:23 ET

Express News | Q32 Bio Inc : Piper Sandler Raises Target Price to $60 From $45

ReutersAug 8 09:16 ET

Express News | Q32 Bio's Cash, Cash Equivalents, And Short-term Investments Of $107.6M As Of June 30, 2024, Expected To Provide Financial Runway Through Four Phase 2 Clinical Milestones And Into Mid-2026

BenzingaAug 8 07:52 ET

Express News | Q32 Bio Q2 2024 GAAP EPS $(1.42) Misses $(1.04) Estimate

BenzingaAug 8 07:52 ET

Press Release: Q32 Bio Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Dow JonesAug 8 07:38 ET

Q32 Bio | 10-Q: Quarterly report

SEC announcementAug 8 07:14 ET · Announcements